Post Content
The health insurance lobby has been living rent-free inside Washington’s head for years, and on Monday it finally collected the lease. The Centers for Medicare & Medicaid Services finalized a 2.48% average payment increase for Medicare Advantage plans in 2027, amounting to $13 billion in additional funding. Back in January, the agency had proposed a nearly flat 0.09% bump worth around $700 million. Plot twist!
Markets responded accordingly. UnitedHealth jumped 8% (underdog story of the year, you guys), Humana popped 5%, and CVS cleared 4%, the kind of afternoon that makes health insurance executives feel briefly, dangerously, like they are winning. The rate is not exactly a gusher in isolation, but it gives insurers room to expand margins in 2027 if they keep doing what they do best: trimming benefits and managing costs.
The 2.48% headline figure also understates the actual windfall. Fold in estimated risk score trends driven by population changes and coding practices, and the effective increase lands closer to 5%. Coding practices are the polite term for a game the industry has been running for years, upcoding patients to appear sicker than they are to unlock higher government payments. The agency says it wants to clean that up, while simultaneously handing insurers their biggest rate increase since last year’s 5.06%. The jury on that commitment remains out.
The agency’s administrator is Dr. Mehmet Oz (never not funny) who called it a win for seniors and taxpayers alike. The stocks suggest someone is winning. Taxpayers can figure out which column they fall in.
-
UnitedHealth Group (UNH) — The company’s stock jumped 8% immediately following the announcement of increased Medicare Advantage payment rates, providing an opportunity for margin expansion in 2027.
-
Humana Inc. (HUM) — The company’s stock popped 5% in response to the finalized 2.48% payment increase for Medicare Advantage plans, signaling improved profitability prospects.
-
CVS Health Corp (CVS) — As the owner of Aetna, CVS saw its stock clear 4% due to the favorable Medicare Advantage payment rate increase, enhancing its health insurance segment’s outlook.
-
Elevance Health Inc. (ELV) — As a major managed care organization, Elevance Health is expected to benefit from the industry-wide increase in Medicare Advantage payments, offering potential for margin growth.
-
Centene Corp (CNC) — Centene, a significant provider of government-sponsored healthcare programs, will likely see a positive impact from the increased Medicare Advantage funding, supporting its revenue and profitability.
-
Cigna Group (CI) — Cigna’s health services and insurance segments are poised to benefit from the higher Medicare Advantage payment rates, contributing to its financial performance.
-
Molina Healthcare Inc. (MOH) — Molina Healthcare, which focuses on government programs, stands to gain from the enhanced Medicare Advantage payments, bolstering its financial outlook.
-
Health Insurance — The industry directly benefits from the Centers for Medicare & Medicaid Services’ decision to increase Medicare Advantage payments by 2.48% for 2027, leading to higher revenue and margin potential.
-
Managed Care — Companies within the managed care sector, which includes Medicare Advantage plans, will see improved financial prospects due to the substantial increase in government funding.
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here.
-
United States — While the US government will incur higher spending, the increased profitability for major US-based health insurers could contribute to corporate tax revenues and economic activity, creating a mixed overall impact on the country.
-
United States Taxpayers — The $13 billion in additional funding for Medicare Advantage plans in 2027 will ultimately be borne by US taxpayers.
-
Medicare Advantage Enrollees (Seniors) — Despite claims of a “win,” the article suggests insurers will “trim benefits and manage costs” to expand margins, potentially leading to reduced coverage or higher out-of-pocket expenses for seniors.
-
Immediate Stock Price Surge — Immediate (0–7 days) The announcement of the 2.48% Medicare Advantage payment increase led to significant stock price jumps for major health insurers like UnitedHealth, Humana, and CVS, reflecting investor optimism about future profitability. Confidence: High.
-
Medium-term Insurer Profitability Expansion — Medium-term (2–6 months) The $13 billion increase in Medicare Advantage payments for 2027 provides a clear pathway for health insurers to expand their profit margins by strategically managing costs and potentially adjusting benefits. Confidence: High.
-
Long-term Government Healthcare Spending Increase — Long-term (6+ months) The finalized payment increase signifies a sustained trend of rising government expenditure on Medicare Advantage, impacting the federal budget and potentially influencing future healthcare policy decisions. Confidence: High.
-
Medium-term Potential for Benefit Trimming — Medium-term (2–6 months) Insurers are explicitly noted to have “room to expand margins… if they keep doing what they do best: trimming benefits and managing costs,” which could lead to reduced coverage or increased out-of-pocket costs for Medicare Advantage enrollees in 2027. Confidence: Medium.
-
Long-term Scrutiny of Coding Practices — Long-term (6+ months) The article highlights the agency’s stated desire to “clean up” “coding practices” that upcode patients for higher payments, suggesting potential future regulatory actions or increased oversight in this area. Confidence: Medium.
↑ Health Insurance Sector Stock Prices — The immediate market reaction shows a significant increase in the stock valuations of major health insurance companies.
↑ Corporate Profits (Health Insurers) — The $13 billion payment increase and margin expansion opportunities are expected to directly boost the profitability of health insurance companies.
↑ Government Healthcare Spending — The Centers for Medicare & Medicaid Services’ decision directly increases federal outlays for Medicare Advantage by $13 billion in 2027.
↓ Disposable Income (US Taxpayers) — The additional $13 billion in government funding for Medicare Advantage plans will ultimately be financed by US taxpayers, reducing their collective disposable income.
↑ Healthcare Sector Investment (Managed Care) — Increased profitability and favorable regulatory decisions are likely to attract more investment into the managed care and health insurance sectors.
One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.
Terms and Privacy Policy